SEC Form 4 · accession 0001061983-15-000009
CYTOKINETICS INC · CYTK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Fady Ibraham Malik
Officer — SVP Research & Development
Period of report
Feb 26, 2015
Accepted (ET)
Mar 2, 2015 · 5:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001061983
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F1 | $7.96 | Feb 26, 2015 | A | 11,678 | A | Mar 26, 2015 | Feb 26, 2025 | Common Stock | 11,678 | 11,678 | D |
| Non-Qualified Stock Option (right to buy)F1 | $7.96 | Feb 26, 2015 | A | 88,322 | A | Mar 26, 2015 | Feb 26, 2025 | Common Stock | 88,322 | 88,322 | D |
Explanation of responses
- F1When the ISO and NQ dated 02/26/2015 are combined for a total grant of 100,000 shares, the option shall vest and become exercisable as to 100,000 shares divided into equal monthly installments such that the option shall be 100% vested on 02/26/2019.